Evidence map›Paper›PMID 39132420›Full record

ArticleJournal of human kinetics2024

Parkinson's Critical Heart Rate Test: Applying the Critical Power Model for People with Parkinson's Disease.

Ricardo Augusto Barbieri, Carlos Augusto Kalva-Filho, Murilo Henrique Faria, Aline Prieto Silveira-Ciola, Camila Torriani-Pasin, Lucas Simieli, Fabio Augusto Barbieri

Abstract read
In one paragraph

Article in Journal of human kinetics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ricardo Augusto BarbieriDepartment for Life Quality Studies, University of Bologna (UNIBO), Rimini, Italy.
Carlos Augusto Kalva-FilhoSchool of Sciences, Department of Physical Education, Human Movement Research Laboratory (MOVI-LAB), São Paulo State University (Unesp), Bauru, SP, Brazil.
Murilo Henrique FariaSchool of Sciences, Department of Physical Education, Human Movement Research Laboratory (MOVI-LAB), São Paulo State University (Unesp), Bauru, SP, Brazil.
Aline Prieto Silveira-CiolaSchool of Sciences, Department of Physical Education, Human Movement Research Laboratory (MOVI-LAB), São Paulo State University (Unesp), Bauru, SP, Brazil.
Camila Torriani-PasinDepartment of Physical Therapy and Movement Sciences, University of Texas, El Paso, USA.
Lucas SimieliSchool of Sciences, Department of Physical Education, Human Movement Research Laboratory (MOVI-LAB), São Paulo State University (Unesp), Bauru, SP, Brazil.
Fabio Augusto BarbieriSchool of Sciences, Department of Physical Education, Human Movement Research Laboratory (MOVI-LAB), São Paulo State University (Unesp), Bauru, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aerobic exercise with the correct intensity can attenuate motor and non-motor symptoms of Parkinson's disease (PD) and improve the quality of life. However, a specific, validated, non-invasive, and outside the laboratory protocol that assesses physiological variables to prescribe optimal aerobic exercise intensity for people with PD is nonexistent. Therefore, this study aimed to propose a protocol, the Parkinson's critical heart rate test (Parkinson-CHR test), to determine the critical heart rate (CHR) in individuals with PD and verify its validity, reliability, and sensitivity. Fifteen people with idiopathic PD, who were able to practice exercises, were recruited to participate in the study (71.1 ± 6.6 years). The study consisted of two experiments: i) the first one aimed to assess the validity and reliability of the protocol, with participants performing the test twice at a one-week interval; ii) the second experiment aimed to investigate the protocol sensitivity, with individuals being evaluated before and after an 8-week training program according to Parkinson-CHR intensity. In experiment 1, no differences between test and retest were observed in the time to cover the distances (400, 800 and 1200 m), the total heart rate, the critical heart rate, and critical speed (p > 0.05). In experiment 2, there was a reduction in time to cover 400 and 800 m as well as in the total heart rate for all distances after the 8-week training program. The Parkinson-CHR test is a reliable, reproducible, inexpensive, and non-invasive protocol to assess, prescribe, and monitor aerobic exercise intensity in people with PD.

Indexed as

aerobic exerciseexercise intensityreliabilitytestingvalidity

Identifiers

PMID39132420
PMCPMC11307192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.